Our findings suggest that IL-38 exerts a potential inhibitory effect on the progression of atherosclerosis in mice by suppressing M1-like macrophage polarization and apoptosis, as well as attenuating the activation of the nuclear factor-κB (NF-κB) signaling pathway. The gene discussed is NFKB1; the disease is atherosclerosis.